Management of Metabolic Alkalosis in Dialysis Patients
Metabolic alkalosis in dialysis patients should be managed by reducing the dialysate bicarbonate concentration to prevent post-dialysis alkalosis, with target pre-dialysis total CO2 of 19-25 mEq/L and post-dialysis total CO2 ≤29 mEq/L. 1
Pathophysiology and Clinical Context
Metabolic alkalosis in dialysis patients typically results from:
- Excessive bicarbonate delivery during dialysis sessions, particularly when using standard high-bicarbonate dialysate (typically 35-40 mEq/L) 1
- Regional citrate anticoagulation, which delivers large amounts of potential bicarbonate (several hundred mEq) and can cause severe metabolic alkalosis 2, 3
- Vomiting or gastrointestinal losses in patients without kidney function 4
Both metabolic acidosis and alkalosis increase hospitalizations, hemodynamic instability, and mortality in hemodialysis patients 1. The current one-size-fits-all approach leaves many patients either acidotic before or alkalotic after dialysis sessions 1.
Management Algorithm
Step 1: Identify the Cause and Severity
For citrate-induced alkalosis:
- Monitor systemic acid-base balance in patients at high risk for citrate accumulation during continuous renal replacement therapy 2
- Citrate anticoagulation has been associated with both metabolic alkalosis and metabolic acidosis 2
For severe metabolic alkalosis:
- Consider using acid dialysate for rapid correction in severe cases 5, 6
- This involves deliberately using the acid concentrate from a two-part bicarbonate dialysis system 5
Step 2: Adjust Dialysate Bicarbonate Concentration
The primary intervention is individualized dialysate bicarbonate adjustment:
- Target pre-dialysis total CO2: 19-25 mEq/L 1
- Target post-dialysis total CO2: ≤29 mEq/L 1
- Most patients (75%) will require dialysate bicarbonate of 32-34 mEq/L to achieve these targets 1
- This approach eliminates pre-dialysis acidosis and post-dialysis alkalosis in >95% of patients 1
Step 3: Monitor and Adjust
Regular monitoring should include:
- Pre- and post-dialysis total CO2 measurements 1
- Serum calcium, phosphorus, and PTH levels (no clinically significant changes expected with bicarbonate adjustment) 1
- Assessment for intradialytic adverse events 1
Special Considerations for Continuous Renal Replacement Therapy (CRRT)
Buffer selection matters:
- Either lactate or bicarbonate can be used as buffer in most CRRT patients 2
- Bicarbonate is preferred in patients with lactic acidosis and/or liver failure 2
- Bicarbonate is preferred in high-volume hemofiltration 2
Dialysate composition:
- Dialysate or substitution fluid should contain physiologic concentrations of electrolytes, except in patients with extreme imbalances 2
- Avoid supra-physiologic glucose concentrations that result in hyperglycemia 2
Critical Pitfalls to Avoid
Do not use standard high-bicarbonate dialysate for all patients:
- The traditional approach of using 35-40 mEq/L bicarbonate dialysate causes post-dialysis alkalosis in many patients 1
- Only 67.9% of patients are within desired target range at baseline with standard prescriptions 1
Monitor citrate anticoagulation closely:
- Regional citrate anticoagulation can deliver several hundred mEq of potential bicarbonate 3
- Frequent measurements of post-filter and serum-ionized calcium should be performed 2
- Monitoring of systemic acid-base balance is advisable in patients at high risk for citrate accumulation 2
Avoid excessive correction:
- In severe acute acidemia (not alkalosis), overly rapid correction can cause paradoxical CNS acidosis and cerebral edema 7
- The goal is to achieve target ranges, not to overcorrect 1
Treatment Efficacy
Evidence supports individualized bicarbonate adjustment: